Average Co-Inventor Count = 6.94
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ariad Pharmaceuticals, Inc. (34 from 69 patents)
2. Astrazeneca Ab (1 from 1,500 patents)
3. Takeda Pharmaceutical Company Limited (1 from 1,179 patents)
4. Dalgarno, David C. (0 patent)
5. Zhu, Xiaotian (0 patent)
6. Wang, Yihan (0 patent)
7. Huang, Wei-sheng (0 patent)
8. Shakespeare, William C. (0 patent)
36 patents:
1. 11958850 - Heteroaryl compounds for kinase inhibition
2. 11753404 - Aminothiazole compounds as c-Kit inhibitors
3. 11117883 - Benzimidazole compounds as c-Kit inhibitors
4. 11001580 - Aminothiazole compounds as c-Kit inhibitors
5. 10227342 - Heteroaryl compounds for kinase inhibition
6. 9834521 - Choline kinase inhibitors
7. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
8. 9834518 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
9. 9796712 - Heteroaryl compounds for kinase inhibition
10. 9611283 - Methods for inhibiting cell proliferation in ALK-driven cancers
11. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
12. 9273077 - Phosphorus derivatives as kinase inhibitors
13. 9090561 - Acetylenic heteroaryl compounds
14. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
15. 9012462 - Phosphorous derivatives as kinase inhibitors